Literature DB >> 29769970

The Canadian Institutes of Health Research response to antimicrobial resistance.

E L Pagé1, S Desnoyers1, I J Létourneau1, K Keown2, A Jackson2, M Ouellette1.   

Abstract

Antimicrobial resistance (AMR) has been a research priority for the Canadian Institutes of Health Research (CIHR), Institute of Infection and Immunity (III) since its inception, and a number of strategic research initiatives have been launched to address this global health problem by promoting and supporting research related to mechanisms and processes that impact the emergence and spread of resistance among individuals and within the environment. Here we will present research initiatives on AMR led by CIHR-III, which include national programs as well as international partnerships with the United Kingdom and the European Union, in addition to interesting outcomes of these initiatives.

Year:  2015        PMID： 29769970      PMCID： PMC5868538          DOI： 10.14745/ccdr.v41is5a03

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


  11 in total

1.  Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamase.

Authors:  Caitlyn M Rotondo; Laura Marrone; Valerie J Goodfellow; Ahmad Ghavami; Geneviève Labbé; James Spencer; Gary I Dmitrienko; Stefan Siemann
Journal:  Biochim Biophys Acta       Date:  2015-08-01

2.  Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients.

Authors:  Andrew E Simor; Marianna Ofner-Agostini; Shirley Paton; Allison McGeer; Mark Loeb; Elizabeth Bryce; Michael Mulvey
Journal:  Infect Control Hosp Epidemiol       Date:  2005-10       Impact factor: 3.254

3.  Antimicrobial susceptibilities of Campylobacter jejuni isolates from poultry from Alberta, Canada.

Authors:  Veronica N Kos; Monika Keelan; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 4.  The biology of Mur ligases as an antibacterial target.

Authors:  Imène Kouidmi; Roger C Levesque; Catherine Paradis-Bleau
Journal:  Mol Microbiol       Date:  2014-09-05       Impact factor: 3.501

5.  Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.

Authors:  Diana D Semler; Amanda D Goudie; Warren H Finlay; Jonathan J Dennis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

6.  Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase.

Authors:  Maya A Farha; Tomasz L Czarny; Cullen L Myers; Liam J Worrall; Shawn French; Deborah G Conrady; Yang Wang; Eric Oldfield; Natalie C J Strynadka; Eric D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

7.  The state of infection surveillance and control in Canadian acute care hospitals.

Authors:  Dick E Zoutman; B Douglas Ford; Elizabeth Bryce; Marie Gourdeau; Ginette Hébert; Elizabeth Henderson; Shirley Paton
Journal:  Am J Infect Control       Date:  2003-08       Impact factor: 2.918

8.  Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006.

Authors:  L F Mataseje; N Neumann; B Crago; P Baudry; G G Zhanel; M Louie; M R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

9.  Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.

Authors:  Denise Gravel; Mark Miller; Andrew Simor; Geoffrey Taylor; Michael Gardam; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly; David Boyd; Michael Mulvey
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

10.  Assay for drug discovery: Synthesis and testing of nitrocefin analogues for use as β-lactamase substrates.

Authors:  Ahmad Ghavami; Geneviève Labbé; Jürgen Brem; Valerie J Goodfellow; Laura Marrone; Carol A Tanner; Dustin T King; Melinda Lam; Natalie C J Strynadka; Dylan R Pillai; Stefan Siemann; James Spencer; Christopher J Schofield; Gary I Dmitrienko
Journal:  Anal Biochem       Date:  2015-07-02       Impact factor: 3.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.